Wealthspire Advisors, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthspire Advisors, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$424,254
-19.6%
36,292
-7.6%
0.01%
-22.2%
Q2 2023$527,789
-18.9%
39,2700.0%0.01%
-18.2%
Q1 2023$651,097
+1.0%
39,270
+13.3%
0.01%
-8.3%
Q4 2022$644,602
+46.5%
34,656
+1.1%
0.01%
+33.3%
Q3 2022$440,000
-24.1%
34,270
-58.6%
0.01%
-25.0%
Q2 2022$580,000
-15.5%
82,7700.0%0.01%
-20.0%
Q1 2022$686,000
-26.5%
82,770
-39.9%
0.02%
-28.6%
Q4 2021$933,000
-47.9%
137,770
-59.2%
0.02%
-43.2%
Q3 2021$1,790,000
-7.8%
337,7700.0%0.04%
-27.5%
Q2 2021$1,942,000
+24.7%
337,7700.0%0.05%
+37.8%
Q1 2021$1,557,000
+38.0%
337,7700.0%0.04%
+8.8%
Q4 2020$1,128,000
+12.5%
337,7700.0%0.03%
-43.3%
Q3 2020$1,003,000
-35.7%
337,7700.0%0.06%
-45.0%
Q2 2020$1,560,000
+20.0%
337,7700.0%0.11%
+101.9%
Q1 2020$1,300,000337,7700.05%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders